Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer
Bo Hu,1 Ying Yan,2 Fei Tong,1 Long Xu,1 Jia Zhu,1 Guangtao Xu,1 Ruilin Shen1 1Department of Oncopathology, Institute of Diabetes and Urological Disease, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing University, Jiaxing, 2Department of Rehabilitation Medicine, The Third Affiliated Hospit...
Guardado en:
Autores principales: | Hu B, Yan Y, Tong F, Xu L, Zhu J, Xu G, Shen R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f16d12259294966b2dae454175e6d3f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
por: Maria Arista-Romero, et al.
Publicado: (2021) -
Microvessel density as a prognostic indicator of prostate cancer: A systematic review and meta-analysis
por: Feng Guangui, et al.
Publicado: (2021) -
Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery
por: Tsolou A, et al.
Publicado: (2020) -
Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo
por: Xu MQ, et al.
Publicado: (2021) -
Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis
por: Li Y, et al.
Publicado: (2016)